首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Erratum for Rhee et al. Pharmacokinetics Safety and Tolerability of Single and Multiple Doses of Relebactam a β-Lactamase Inhibitor in Combination with Imipenem and Cilastatin in Healthy Participants

【2h】

Erratum for Rhee et al. Pharmacokinetics Safety and Tolerability of Single and Multiple Doses of Relebactam a β-Lactamase Inhibitor in Combination with Imipenem and Cilastatin in Healthy Participants

机译：Rhee等人的勘误健康参与者中单剂量和多剂量雷巴坦（一种β-内酰胺酶抑制剂）与亚胺培南和西司他丁的组合的药代动力学安全性和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Antimicrobial Agents and Chemotherapy
作者
Elizabeth G. Rhee; Matthew L. Rizk; Nicole Calder; Marcela Nefliu; Steven J. Warrington; Michael S. Schwartz; Eric Mangin; Keith Boundy; Pratik Bhagunde; Francheska Colon-Gonzalez; Patricia Jumes; Yang Liu; Joan R. Butterton;
展开▼
作者单位

展开▼
年(卷),期 2018(62),12
年度 2018
页码 e02197-18
总页数 1
原文格式 PDF
正文语种
中图分类药学;微生物学;
关键词
入库时间 2022-08-17 16:07:45

相似文献

外文文献
中文文献
专利

1. Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a beta-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants [J] . Rhee Elizabeth G., Rizk Matthew L., Calder Nicole, Antimicrobial agents and chemotherapy. . 2018,第9期

机译：单一和多剂量的重新分泌物，β-内酰胺酶抑制剂的药代动力学，安全性和可耐受性，与伊皮思姆和香酰胺酰胺组合在健康参与者中
2. Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a beta-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants (vol 62, e00280-18, 2018) [J] . Rhee Elizabeth G., Rizk Matthew L., Calder Nicole, Antimicrobial agents and chemotherapy. . 2018,第12期

机译：单一剂量的药代动力学，安全性和β-内酰胺酶抑制剂的单剂和多剂量的耐受性，与伊皮脂和含有伊替糖蛋白在健康参与者中的组合（Vol 62，E00280-18,2018）组合
3. Intrapulmonary Pharmacokinetics of Relebactam, a Novel beta-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects [J] . Rizk Matthew L., Rhee Elizabeth G., Jumes Patricia A., Antimicrobial agents and chemotherapy. . 2018,第3期

机译：重新纳米酰胺的肺内药代动力学，一种新型β-内酰胺酶抑制剂，与伊替尼 - 西兰替肽组合在健康受试者组合
4. Pharmacokinetics and Tolerability of Sublingual Fentanyl in Healthy Japanese and Caucasian Volunteers: Phase I, Open-Label Single-Dose Study [C] . U. Lorch, F. Farrell, J. Kilborn, International Pain Clinic Congress . 2008

机译：健康日本和白种人志愿者舌下芬太尼的药代动力学和耐受性：I期，开放标签单剂量研究
5. Pharmacokinetics Safety and Tolerability of Single and Multiple Doses of Relebactam a β-Lactamase Inhibitor in Combination with Imipenem and Cilastatin in Healthy Participants [O] . Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder, 2018

机译：β-内酰胺酶抑制剂雷贝巴坦与亚胺培南和西司他丁在健康受试者中的单剂和多剂药代动力学安全性和耐受性
6. Erratum for Rhee et al., “Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants” [O] . Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder, 2018

机译：Rhee等人的错误，“单一剂量，安全性和多剂量，β-内酰胺酶抑制剂的药代动力学，安全性和可耐受性，与伊蛋白酶和β-内酰胺酶抑制剂联合在健康的参与者中”

Erratum for Rhee et al. Pharmacokinetics Safety and Tolerability of Single and Multiple Doses of Relebactam a β-Lactamase Inhibitor in Combination with Imipenem and Cilastatin in Healthy Participants

著录项

相似文献

相关主题

期刊订阅